1. Home
  2. CVAC vs AIOT Comparison

CVAC vs AIOT Comparison

Compare CVAC & AIOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVAC
  • AIOT
  • Stock Information
  • Founded
  • CVAC 2000
  • AIOT 1993
  • Country
  • CVAC Germany
  • AIOT United States
  • Employees
  • CVAC N/A
  • AIOT N/A
  • Industry
  • CVAC Biotechnology: Pharmaceutical Preparations
  • AIOT Telecommunications Equipment
  • Sector
  • CVAC Health Care
  • AIOT Telecommunications
  • Exchange
  • CVAC Nasdaq
  • AIOT Nasdaq
  • Market Cap
  • CVAC 637.1M
  • AIOT 687.0M
  • IPO Year
  • CVAC 2020
  • AIOT N/A
  • Fundamental
  • Price
  • CVAC $2.54
  • AIOT $5.95
  • Analyst Decision
  • CVAC Hold
  • AIOT Buy
  • Analyst Count
  • CVAC 3
  • AIOT 1
  • Target Price
  • CVAC $10.00
  • AIOT $10.00
  • AVG Volume (30 Days)
  • CVAC 540.3K
  • AIOT 1.2M
  • Earning Date
  • CVAC 11-12-2024
  • AIOT 11-12-2024
  • Dividend Yield
  • CVAC N/A
  • AIOT N/A
  • EPS Growth
  • CVAC N/A
  • AIOT N/A
  • EPS
  • CVAC N/A
  • AIOT N/A
  • Revenue
  • CVAC $70,565,734.00
  • AIOT $221,073,000.00
  • Revenue This Year
  • CVAC $123.97
  • AIOT $153.13
  • Revenue Next Year
  • CVAC N/A
  • AIOT $21.07
  • P/E Ratio
  • CVAC N/A
  • AIOT N/A
  • Revenue Growth
  • CVAC 75.11
  • AIOT 67.23
  • 52 Week Low
  • CVAC $2.22
  • AIOT $2.22
  • 52 Week High
  • CVAC $6.30
  • AIOT $6.68
  • Technical
  • Relative Strength Index (RSI)
  • CVAC 34.97
  • AIOT 61.29
  • Support Level
  • CVAC $2.73
  • AIOT $4.80
  • Resistance Level
  • CVAC $2.97
  • AIOT $6.68
  • Average True Range (ATR)
  • CVAC 0.18
  • AIOT 0.38
  • MACD
  • CVAC -0.01
  • AIOT 0.09
  • Stochastic Oscillator
  • CVAC 7.55
  • AIOT 62.18

About CVAC CureVac N.V.

CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.

About AIOT PowerFleet Inc. Common Stock

PowerFleet Inc is engaged in Internet-of-Things (IoT) solutions providing valuable business intelligence for managing high-value enterprise assets that improve operational efficiencies. It provide critical information that powers unified operations throughout organizations. It is solving the challenge of inefficient data collection, real-time visibility, and analysis that leads to transformative business operations. Its SaaS cloud-based applications take data from IoT devices and ecosystem of third-party and partner applications to present actionable information for customer.

Share on Social Networks: